TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/24 19:41 | 9/20/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | M.dm | 764 | 51.80 | 0 | 15 | 41 | 51 | D | ||||||||||||||
9/24/24 19:41 | 9/20/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.dm | -1,642 | 102.35 | 0 | -16 | -24 | 51 | D | ||||||||||||||
9/18/24 19:55 | 9/16/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | M.d | 338 | 58.49 | 0 | 6 | 12 | 52 | D | ||||||||||||||
8/26/24 20:15 | 8/22/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.m | -1,986 | 105.34 | 0 | -19 | -28 | 50 | D | ||||||||||||||
8/13/24 17:21 | 8/9/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S | -1,797 | 98.50 | 0 | -18 | -21 | 68 | D | ||||||||||||||
5/15/24 19:34 | 5/13/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Korenberg Matthew E | FL | O | P,COO | S.m | -1,496 | 84.99 | 0 | -18 | -17 | 86 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |